Aerie Pharmaceuticals to Announce Second Quarter 2021 Financial Results and Host Conference Call on Wednesday, August 4, 2021
Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Companys financial results and provide a general business update.
- Following the release, the Company will host a live conference call and webcast at 5:00 p.m. Eastern Time to discuss the Companys financial results and provide a general business update.
- The live webcast and a replay may be accessed by visiting the Companys website at http://investors.aeriepharma.com .
- Alternatively, please call (888) 734-0328 (U.S.) or (678) 894-3054 (international) to listen to the live conference call.
- In clinical trials of Rhopressa, the most common adverse reactions were conjunctival hyperemia, corneal verticillata, instillation site pain, and conjunctival hemorrhage.